Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 22 May 2007
Vol. 2007, Issue 387, p. tw177
[DOI: 10.1126/stke.3872007tw177]

EDITORS' CHOICE

Medicine Tumor Suppressor Joined to Wnt Network

Paula A. Kiberstis

Science, AAAS, Washington, DC 20005, USA

Elucidation of the cellular signaling pathways that contribute to cancer development often begins with the identification of a gene mutated in human tumors. Complementary biochemical approaches become especially important when the sequence of the newly identified gene provides few clues as to its function. Major et al. used analysis of protein interaction networks to define the function of WTX, a tumor suppressor gene found very recently to be mutated in an inherited kidney cancer called Wilms tumor. The WTX protein forms a complex with several proteins in the Wnt signaling cascade, including beta-catenin, Axin1, beta-TRCP2 (beta-transducin repeat-containing protein 2), and APC (adenomatous polyposis coli), and antagonizes Wnt signaling by promoting beta-catenin degradation.

M. B. Major, N. D. Camp, J. D. Berndt, X. Yi, S. J. Goldenberg, C. Hubbert, T. L. Biechele, A.-C. Gingras, N. Zheng, M. J. MacCoss, S. Angers, R. T. Moon, Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316, 1043-1046 (2007). [Abstract] [Full Text]

R. Nusse, Converging on beta-catenin in Wilms tumor. Science 316, 988-989 (2007). [Summary] [Full Text]

Citation: P. A. Kiberstis, Tumor Suppressor Joined to Wnt Network. Sci. STKE 2007, tw177 (2007).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882